ai& and Tenstorrent launched JapanFold on September 3, 2026, a drug discovery platform serving open-source structural biology models entirely on infrastructure inside Japan. The platform runs on ai&’s sovereign infrastructure powered by Tenstorrent Galaxy superclusters, and the companies say every computation executes within the country. Japanese researchers, pharmaceutical companies, and biotech firms can access the models at what the companies describe as a fraction of the cost of…